Overview
ISIN | GB00BRC89928 |
---|---|
Share Class | Income |
Ongoing Charge | - |
Annual Management Charge | - |
Midprice | 1.00p |
---|---|
Change on Day | 0.00p |
Change on Day % | 0% |
52 week high | 1.00p |
52 week low | 1.00p |
Fund currency | GBX |
Date updated | 20 June 2025 |
Fund Type | Closed Ended Investment Company |
---|---|
Unit Type | Income |
Standard initial Charge | - |
Annual Management Charge | - |
Dividend Frequency | Annually |
Latest Distribution Info |
- |
Fund Manager Company | Shore Capital |
---|
Name | Stuart Rollason |
---|---|
Since | 02 April 2025 |
Bio | Stuart Rollason has been working with the AIM market since its inception in 1995. He began his career in the financial industry as a broker research analyst analysing AIM stocks. In 2000 he became a fund manager, being part of a team that launched an investment trust focused on AIM, including VCT qualifying companies, as well as private companies. He managed a smaller company open-ended trust and was part of a team that managed an investment trust and a VCT. In 2011, he began managing an AIM inheritance tax service. Stuart joined Puma Investments in 2021 to manage the Service. Before joining Puma Investments, he was a partner at Kestrel Partners LLP, where he led its AIM inheritance tax service for a decade. In that time the Kestrel Inheritance Tax Solution portfolio produced a strong performance, delivering a compound annual growth rate of 12.38% pa to 31 March 2021 (source: Puma Investments with numbers unaudited). Prior to Kestrel, Stuart was part of an investment team that managed the Active Capital Trust plc, The AIM VCT plc and AIM VCT 2 (which was renamed Bluehone AIM VCT 2 plc). The two VCTs were subsequently merged and Stuart was part of the investment management team that managed the merged VCTs as Bluehone AIM VCT 2 plc. Stuart also managed £230 million of UK smaller company pension assets at ISIS Asset Management. Stuart was formerly an Extel-rated Research Analyst in Medical Technology and Biotech at Beeson Gregory, Panmure Gordon and Nomura, and began his career as a medical doctor practising in the NHS, before moving into research at Oxford University. |
Name | Daniel Cane |
---|---|
Since | 02 April 2025 |
Bio | Daniel joined Puma Investments in September 2024. Previously he had spent 16 years at Toscafund Asset Management where he was involved with the AIM focused Toscafund Micro Cap Fund, as well as the ECM fund, Tosca Focus and the Tosca Mid Cap fund. Prior to Toscafund Daniel began his career as a research analyst at Gerrard Vivian Gray before joining ABN AMRO Hoare Govett, where he become an Extel-rated paper/ packaging sector analyst. Latterly he was at HSBC covering general retail and then in a specialist sales role at QuantMetriks, a boutique data-driven research house. |
Name | Joseph Cornwall |
---|---|
Since | 02 April 2025 |
Bio | Joseph joined Puma Investments in 2021 as part of the Puma AIM team. Prior to working at Puma, he led the AIM Inheritance Tax service at Gore Browne Investment Management for five years, following a career as a professional sportsman. Joseph studied for a degree in Management at the University of Warwick’s Business School. He is a Chartered Fellow of the Chartered Institute for Securities & Investment and a CFA Charterholder. |